netFormulary
 Report : A-Z CDF items in Formulary 31/10/2020 21:49:12
[Back]
 
Section Status CDF Name
08.03.04.02 Formulary Cancer Drugs Fund Abiraterone acetate Zytiga®
08.01.05 Formulary Cancer Drugs Fund Alectinib hydrochloride Alecensa®
08.01.05 Formulary Cancer Drugs Fund Arsenic trioxide Trisenox®
08.01.05 Formulary Cancer Drugs Fund Atezolizumab Tecentriq®
08.01.05 Formulary Cancer Drugs Fund Avelumab Bavencio®
08.02.04 Formulary Cancer Drugs Fund Axicabtagene ciloleucel Yescarta®
08.01.01 Formulary Cancer Drugs Fund Bendamustine hydrochloride 
08.02.03 Formulary Cancer Drugs Fund Blinatumomab Blincyto®
08.01.05 Formulary Cancer Drugs Fund Bortezomib Velcade®
08.01.05 Formulary Cancer Drugs Fund Bosutinib Bosulif®
08.01.05 Formulary Cancer Drugs Fund Brentuximab vedotin Adcetris®
08.01.05 Formulary Cancer Drugs Fund Cabazitaxel Jevtana®
08.01.05 Formulary Cancer Drugs Fund Cabozantinib Cabometyx®
08.01.05 Formulary Cancer Drugs Fund Carfilzomib Kyprolis®
08.01.05 Formulary Cancer Drugs Fund Cemiplimab Libtayo®
08.01.05 Formulary Cancer Drugs Fund Ceritinib Zykadia®
08.01.05 Formulary Cancer Drugs Fund Cetuximab Erbitux®
08.01.05 Formulary Cancer Drugs Fund Crizotinib Xalkori®
08.01.05 Formulary Cancer Drugs Fund Dabrafenib mesilate Tafinlar®
08.01.05 Formulary Cancer Drugs Fund Daratumumab Darzalex®
08.01.05 Formulary Cancer Drugs Fund Dasatinib Sprycel®
08.01.05 Formulary Cancer Drugs Fund Dinutuximab beta Qarziba®
08.01.05 Formulary Cancer Drugs Fund Doxorubicin hydrochloride Caelyx®
08.03.04.02 Formulary Cancer Drugs Fund Enzalutamide Xtandi®
08.01.05 Formulary Cancer Drugs Fund Eribulin Halaven®
08.01.05 Formulary Cancer Drugs Fund Gemtuzumab ozogamicin Mylotarg®
08.01.05 Formulary Cancer Drugs Fund Ibrutinib Imbruvica®
08.01.05 Formulary Cancer Drugs Fund Inotuzumab ozogamicin Besponsa®
08.01.05 Formulary Cancer Drugs Fund Ipilimumab Yervoy®
08.01.05 Formulary Cancer Drugs Fund Ixazomib Ninlaro®
08.01.05 Formulary Cancer Drugs Fund Larotrectinib 
08.02.04 Formulary Cancer Drugs Fund Lenalidomide Revlimid®
08.01.05 Formulary Cancer Drugs Fund Lenvatinib 
08.01.05 Formulary Cancer Drugs Fund Lorlatinib 
08.03.04.03 Formulary Cancer Drugs Fund Lutetium (177Lu) oxodotreotide 
08.01.05 Formulary Cancer Drugs Fund Midostaurin Rydapt ®
08.01.05 Formulary Cancer Drugs Fund Nilotinib Tasigna®
08.01.05 Formulary Cancer Drugs Fund Niraparib Zejula®
08.01.05 Formulary Cancer Drugs Fund Nivolumab Opdivo®
08.02.03 Formulary Cancer Drugs Fund Obinutuzumab Gazyvaro®
08.01.05 Formulary Cancer Drugs Fund Olaparib Lynparza®
08.01.05 Formulary Cancer Drugs Fund Olaratumab Lartruvo®
08.01.05 Formulary Cancer Drugs Fund Osimertinib Tagrisso®
08.01.05 Formulary Cancer Drugs Fund Palbociclib Ibrance®
08.01.05 Formulary Cancer Drugs Fund Panitumumab Vectibix®
08.01.05 Formulary Cancer Drugs Fund Panobinostat Farydak®
08.01.05 Formulary Cancer Drugs Fund Pembrolizumab Keytruda®
08.01.03 Formulary Cancer Drugs Fund Pemetrexed disodium Alimta®
08.01.05 Formulary Cancer Drugs Fund Pertuzumab Perjeta®
08.02.04 Formulary Cancer Drugs Fund Pomalidomide Imnovid®
08.01.05 Formulary Cancer Drugs Fund Ponatinib Iclusig®
08.01.05 Formulary Cancer Drugs Fund Regorafenib Stivarga®
08.01.05 Formulary Cancer Drugs Fund Ribociclib succinate Kisqali®
08.02.04 Formulary Cancer Drugs Fund Rucaparib Rubraca®
08.01.05 Formulary Cancer Drugs Fund Ruxolitinib phosphate Jakavi®
08.01.05 Formulary Cancer Drugs Fund Sunitinib Sutent®
08.01.05 Formulary Cancer Drugs Fund Talimogene laherparepvac Imlygic®
08.01.05 Formulary Cancer Drugs Fund Tisagenlecleucel Kymriah®
08.01.05 Formulary Cancer Drugs Fund Tivozanib Fotivda®
08.01.05 Formulary Cancer Drugs Fund Trametinib Mekinist®
08.01.05 Formulary Cancer Drugs Fund Trastuzumab 
08.01.05 Formulary Cancer Drugs Fund Trastuzumab emtansine 
08.01.05 Formulary Cancer Drugs Fund Trifluridine-tipiracil Lonsurf®
08.01.05 Formulary Cancer Drugs Fund Venetoclax Venclyxto®
North Staffordshire Joint Formulary